Browse drugs

… fever or trauma. Initial cranial CT excluded acute stroke, and levetiracetam dose was decreased (500 mg/48h) as it can cause lethargy. Withi…

…tions and had 1.1 PIMs. The most frequent PIM drug classes were proton pump inhibitors (28%), benzodiazepines (16%), and antipsychotics (11%). Among t…

…als, leading to an ongoing need to develop novel antibiotics. 1 Gepotidacin is a first-in-class oral antibiotic that was approved recently …

…pofol infusion (100–150 µg/kg/min), fentanyl (2 µg/kg/hour) and dexmedetomidine (1 µg/kg over 15 min followed by 0.5 µg/kg/min) to maintain a B…

… microbiota-preserving strategies could enhance the efficacy of BsAb therapy in MM.…

…e in the primary endpoint and secondary endpoints compared with certolizumab monotherapy in participants with active RA.…

…ing for sustained remission or low disease activity (LDA), with prednisone (PDN) <=5 mg/day and withdrawal when possible. However, real-wo…

…teristics of SLE patientsConclusions In this real-world cohort, belimumab treatment was associated with significant improvements in disea…

… (29.4%) patients. Glucocorticoids were received by 41 (80.4%), hydroxychloroquine - 38 (74.5%), immunosuppressants – 18 (35.3%) patients. Over th…

…r in SLE compared to controls across all trimesters (p=0.0001). Endostatin, but not angiogenin, was enriched in placental intervillous blo…

…tment escalation, including GC, azathioprine (150 mg/daily) and hydroxychloroquine (400 mg/daily). However, only hemoglobin levels improved, while…

…frolumab treatmentConclusions In this real-world Danish cohort, anifrolumab produced substantial and sustained reductions in disease activi…